Genetics and kidney disease progression study
Part of Blood & lymphatic, Bones, joints & muscles, Cancer, Genetic & congenital, Heart & circulation, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study looks at how genetics affect the progression of kidney diseases. Joining may help researchers understand your condition better and find better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a specific kidney disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study enrolls people who have been diagnosed with autosomal dominant polycystic kidney disease (ADPKD), a genetic kidney condition that can cause kidney cysts. It aims to learn about this specific form of the disease so better care is possible for the right patients.
This study looks at whether simple blood test results (levels of certain white blood cells and platelets) can help predict how quickly chronic kidney disease may get worse. If you join, researchers will track your kidney function over time to see if these blood levels are linked to faster progression.
This study looks at how genes affect kidney disease in people from diverse backgrounds. It may help researchers understand why some people get kidney disease and others don't, which could lead to better prevention and treatment.
This study looks at tiny genetic pieces in your blood to find markers that might help track kidney disease. If you join, researchers will compare these markers between healthy people, people with high blood pressure, and people with chronic kidney disease.
This study tests different treatments for people with advanced kidney disease, including those on dialysis or with a kidney transplant. It aims to find better ways to manage the condition and improve outcomes.
This study enrolls adults with autosomal dominant polycystic kidney disease (ADPKD) to better understand the disease and its related changes in the body. It may help researchers find improved ways to track the condition and support future treatments.
Hear when a new AKI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.